Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D5NV
|
|||
| Former ID |
DIB010298
|
|||
| Drug Name |
GC-1109
|
|||
| Synonyms |
Anthrax vaccine (intramuscular), Korea Green Cross/ KCDC; Anthrax vaccine (intramuscular), Korea Green Cross/ Korea Center for Disease Control and Prevention
Click to Show/Hide
|
|||
| Indication | Bacillus anthracis infection [ICD-11: 1G40] | Phase 2 | [1] | |
| Company |
Korea Center for Disease Control & Prevention
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01624532) A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.